MedTrace Logo

Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women

NCT06604234 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 245

Last updated 2025-12-04

No results posted yet for this study

Summary

In this randomized, placebo-controlled, double-blind study, we aim to investigate if the active product consisting of a probiotic blend can improve the quality of life and alleviate symptoms in peri- and postmenopausal women, using validated questionnaires.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

Combination of Levilactobacillus brevis KABP-052, Lactiplantibacillus plantarum KABP-051 and Pediococcus acidilactici KABP-021 in concentration of 1E09 CFU/capsule

OTHER

Placebo

Placebo comparator containing maltodextrin

Sponsors & Collaborators

  • AB Biotics, SA

    lead INDUSTRY

Principal Investigators

  • Silvia González Rodríguez · HM hospitales

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2024-12-14
Completion
2025-01-17

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06604234 on ClinicalTrials.gov